12.11.2024 14:06:06
|
Novavax Inc. Q3 Loss Decreases, Beats Estimates
(RTTNews) - Novavax Inc. (NVAX) released Loss for third quarter that decreased from last year and beat the Street estimates.
The company's bottom line totaled -$121.30 million, or -$0.76 per share. This compares with -$130.78 million, or -$1.26 per share, in last year's third quarter.
Analysts on average had expected the company to earn -$0.83 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 54.8% to $84.51 million from $186.99 million last year.
Novavax Inc. earnings at a glance (GAAP) :
-Earnings (Q3): -$121.30 Mln. vs. -$130.78 Mln. last year. -EPS (Q3): -$0.76 vs. -$1.26 last year. -Revenue (Q3): $84.51 Mln vs. $186.99 Mln last year.
-Guidance: Full year revenue guidance: $650 - $700 Mln
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novavax Inc.mehr Nachrichten
11.11.24 |
Ausblick: Novavax präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net) | |
08.08.24 |
Umsatz von Novavax fällt deutlich - Novavax-Aktie dennoch höher (finanzen.at) | |
07.08.24 |
Ausblick: Novavax zieht Bilanz zum jüngsten Jahresviertel (finanzen.net) |
Analysen zu Novavax Inc.mehr Analysen
Aktien in diesem Artikel
Novavax Inc. | 8,29 | -1,45% |